Remedent Stock Performance
| REMI Stock | USD 0.0006 0.0001 20.00% |
Remedent holds a performance score of 15 on a scale of zero to a hundred. The company holds a Beta of 1.79, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Remedent will likely underperform. Use Remedent information ratio, skewness, as well as the relationship between the Skewness and day median price , to analyze future returns on Remedent.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Remedent are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain primary indicators, Remedent demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Remedent |
Remedent Relative Risk vs. Return Landscape
If you would invest 0.02 in Remedent on September 27, 2025 and sell it today you would earn a total of 0.04 from holding Remedent or generate 200.0% return on investment over 90 days. Remedent is currently generating 2.2656% in daily expected returns and assumes 11.7865% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Remedent, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Remedent Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Remedent's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Remedent, and traders can use it to determine the average amount a Remedent's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1922
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | REMI | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Remedent is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Remedent by adding it to a well-diversified portfolio.
Remedent Fundamentals Growth
Remedent Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Remedent, and Remedent fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Remedent Pink Sheet performance.
| Return On Equity | 0.042 | |||
| Return On Asset | 0.0096 | |||
| Profit Margin | 0.33 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 3.36 M | |||
| Shares Outstanding | 20 M | |||
| Price To Earning | 1.55 X | |||
| Price To Book | 0.75 X | |||
| Price To Sales | 8.46 X | |||
| Revenue | 401.9 K | |||
| EBITDA | 90.24 K | |||
| Cash And Equivalents | 83.3 K | |||
| Total Debt | 9.43 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 0.24 X | |||
| Cash Flow From Operations | 250.56 K | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 6 M | |||
| Retained Earnings | (21 M) | |||
| Current Asset | 3 M | |||
| Current Liabilities | 3 M |
About Remedent Performance
By evaluating Remedent's fundamental ratios, stakeholders can gain valuable insights into Remedent's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Remedent has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Remedent has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Remedent, Inc., through its subsidiaries, researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products. The company was founded in 1986 and is headquartered in Ghent, Belgium. Remedent operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 3 people.Things to note about Remedent performance evaluation
Checking the ongoing alerts about Remedent for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Remedent help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Remedent is way too risky over 90 days horizon | |
| Remedent has some characteristics of a very speculative penny stock | |
| Remedent appears to be risky and price may revert if volatility continues | |
| About 36.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Remedent's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Remedent's stock is overvalued or undervalued compared to its peers.
- Examining Remedent's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Remedent's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Remedent's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Remedent's pink sheet. These opinions can provide insight into Remedent's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Remedent Pink Sheet analysis
When running Remedent's price analysis, check to measure Remedent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Remedent is operating at the current time. Most of Remedent's value examination focuses on studying past and present price action to predict the probability of Remedent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Remedent's price. Additionally, you may evaluate how the addition of Remedent to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |